Article
Interventions to support decision making in people considering germline genetic testing for BRCA 1/2 pathogenic and likely pathogenic variants: A scoping review.
Journal of genetic counseling - 1 Apr 2024
Pozzar Rachel A, Seven Memnun
Abstract excerpt
Pathogenic and likely pathogenic variants in BRCA1 and BRCA2 (BRCA1/2) are medically actionable and may inform hereditary breast and ovarian cancer (HBOC) treatment and prevention. However, rates of germline genetic testing (GT) in people with and without cancer are suboptimal. Individuals' knowledge, attitudes, and beliefs may influence GT decisions. While genetic counseling (GC) provides decision support, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
